Execution-Focused CMC and External Supply Advisory
RELIABLE SUPPLY. DELIVERED.
CMC, manufacturing, and supply chain leadership supporting pharmaceutical organizations from late-stage development through reliable commercial supply across global external manufacturing networks.
Serving emerging and development-stage pharmaceutical companies, commercial pharmaceutical organizations, and investors.
Focused on execution in complex CDMO environments where performance, speed to market, and reliable supply are critical.
Nearly Three Decades of Operational Leadership
Real-World CDMO Expertise
Proven Commercialization Experience
Experienced in Both Building and Fixing CDMO Networks
Lean Operating Model Expertise
Trusted Advisor to Leadership Teams and Investors
How We Support Your Organization
External Manufacturing Strategy
Design, optimize, and manage CDMO networks for scalable, reliable commercial supply
CMC and Commercialization Execution
Lead development through commercialization with speed, control, and execution certainty
Supply Chain and Operational Leadership
Strengthen supply performance, mitigate risk, and ensure continuity of supply
Product and Platform Expertise
Small molecule expertise across drug substance, drug product, delivery systems, and packaging platforms
Drug Substance
API Manufacturing
Sterile and Injectable Systems
Sterile drug products and prefilled syringe systems
Traditional Dosage Forms
Solid oral dosage forms – capsules and tablets
Combination Products
Prefilled syringes, implants, and drug-device systems
Novel & Complex Dosage Forms
Modified release and advanced delivery systems
Traditional and Complex Packaging
Primary and Secondary Packaging
Who We Work With
Kokoro Consulting works with pharmaceutical organizations and investors navigating complex manufacturing, external supply, and commercialization challenges.
Development-stage Pharmaceutical Companies
Supporting late-stage development across manufacturing strategy, tech transfer, and commercial readiness
CDMO Strategy | CMC Leadership | Technical Operations Buildout | Launch Readiness
Commercial Pharmaceutical Companies
Strengthening external manufacturing strategy, CDMO governance, and global supply reliability
CDMO Governance and Oversight | Second Sourcing | Tech Transfer Strategy | Revalidations and CPV
Investors and Private Equity
Providing expert insight into operational readiness, manufacturing scalability, and supply chain risk
Technical Due Diligence | Risk Management & Mitigation | Scalability Assessment | CDMO Evaluation
Portfolio Companies
Supporting organizations with manufacturing strategy, operational execution, and interim leadership
Technical Operations Leadership | Interim Leadership | Commercial Readiness | CMC Strategy
Engagements are focused where execution risk is high and experienced operational leadership is required.
Advisory Services
Kokoro Consulting provides execution-focused leadership across external manufacturing, CMC strategy, and global supply operations.
We work with pharmaceutical organizations navigating high-risk transitions from development to commercial supply, with a focus on CDMO performance, governance, and supply reliability.
Engagements are focused where execution risk is high and experienced operational leadership is required.
-
Designing and managing external manufacturing networks to ensure reliable, scalable commercial supply.
When we engage:
Preparing for commercial launch without established manufacturing infrastructure
Underperforming CDMO relationships impacting timelines or supply
Establishing governance, oversight, and performance management across global partners
Core capabilities:
CDMO selection, evaluation, and onboarding strategy
Governance frameworks and operating models
Performance management and KPI development
Technical and operational oversight
Supply agreement strategy and negotiation
-
Leading CMC strategy and execution to transition products from development into reliable commercial supply.
When we engage:
Transitioning from Phase 2/3 into commercial readiness
CMC strategy misaligned with commercial manufacturing requirements
Accelerated timelines requiring disciplined execution
Core capabilities:
CMC strategy development and alignment
Development to commercial transition strategy and planning
Process validation strategy
Regulatory CMC strategy and execution
Cross-functional leadership across Quality, Regulatory, and Supply Chain
-
Executing technology transfers and ensuring readiness for reliable, sustained commercial supply.
When we engage:
Transferring processes between CDMOs or from internal to external manufacturing networks
Preparing for commercial launch or scale-up execution
Delays or issues during transfer execution impacting timelines or supply
Core capabilities:
Tech transfer planning and execution
Process scale-up and validation strategy and execution
Site readiness and operational alignment across manufacturing and quality functions
Transfer risk assessment and mitigation planning
Risk identification and mitigation
Troubleshooting during transfer execution and startup
-
Providing experienced operational leadership to drive manufacturing, CMC, and supply chain performance.
When we engage:
Gaps in internal leadership across technical operations or supply chain
Need for experienced leadership during critical decision-making phases
Organizational scaling, restructuring, or operating model redesign
Core capabilities:
Interim leadership across technical operations and supply chain
Strategic advisory to executive leadership teams
Organizational design and operating model development
Cross-functional leadership and alignment
Decision support during high-risk execution and commercialization
Building and leading technical operations organizations from the ground up
-
Providing investors with operational diligence and execution oversight across portfolio companies.
When we engage:
Evaluating manufacturing scalability and risk pre- and post-investment
Portfolio companies lacking experienced technical operations or supply chain leadership
Identifying and mitigating manufacturing and supply chain risk
Core capabilities:
Technical and operational due diligence
CDMO evaluation, governance assessment, and risk identification
Manufacturing scalability and readiness assessment
Portfolio company execution oversight and advisory
Value creation through operational improvement and supply chain performance
Rapid assessment and stabilization of at-risk manufacturing and supply operations
-
Stabilizing supply and restoring performance in underperforming manufacturing networks.
When we engage:
Recurring deviations, batch failures, or persistent quality issues
Missed delivery timelines or sustained supply disruptions
Lack of clear root cause or ineffective remediation strategies
Core capabilities:
Root cause investigation and resolution of complex manufacturing issues
CDMO performance recovery strategy and execution
Deviation and CAPA strategy and execution
Supply stabilization and continuity strategy
Ongoing oversight, performance management, and stabilization tracking
Rapid stabilization of at-risk supply chains and manufacturing operations
Proven Commercialization Experience
Leadership supporting multiple pharmaceutical product launches and delivering reliable commercial supply.
Why Kokoro
Kokoro Consulting brings nearly three decades of pharmaceutical manufacturing, CMC, and global supply chain leadership, focused on execution in complex external manufacturing environments.
We support organizations navigating the transition from development to commercial supply, helping design and manage scalable manufacturing strategies without unnecessary infrastructure.
Experience & Expertise
Experienced Operational Leadership
Nearly three decades of pharmaceutical manufacturing, CMC, and supply chain leadership.
Real World CDMO Expertise
Deep experience building and managing global external manufacturing networks.
Proven Commercialization Experience
Leadership supporting multiple pharmaceutical product launches.
Building and Fixing CDMO Networks
Expertise in designing external manufacturing strategies and remediating underperforming CDMO relationships to restore supply reliability.
Trusted Advisor to Leadership Teams and Investors
Providing independent operational insight across manufacturing and supply.
The Meaning Behind Kokoro
Kokoro is a Japanese concept representing the integration of mind, heart, and intention.
It reflects a balanced approach to decision-making, combining strategic thinking with practical execution. This philosophy guides Kokoro Consulting’s approach to helping organizations navigate complex manufacturing and supply challenges with clarity, discipline, and experience.
About the Founder
Kokoro Consulting was founded by Ron Casey, a pharmaceutical operations leader with nearly three decades of experience across CMC, manufacturing, and global supply chain strategy.
Ron has led external manufacturing and supply networks supporting late-stage development through commercial operations, with deep experience in small molecule drug products, sterile injectables, and complex drug delivery systems.
His background includes building and managing global CDMO networks, leading technology transfers, and supporting multiple pharmaceutical product launches. He has also partnered with investors and portfolio companies to assess operational readiness, manufacturing scalability, and supply chain risk.
Throughout his career, Ron has worked across North America, Europe, and Asia, developing manufacturing strategies and governance models that enable reliable, scalable commercial supply.
Kokoro Consulting reflects his approach to leadership and problem-solving, combining strategic insight with practical execution to deliver results in complex manufacturing environments.
Start a Conversation
If you are preparing for commercialization, addressing CDMO performance issues, or evaluating manufacturing strategy, Kokoro Consulting is available to support.
All inquiries are handled confidentially. We respond within 1–2 business days.